Literature DB >> 16393247

Alphavbeta6 integrin in wound healing and cancer of the oral cavity.

G J Thomas1, M L Nyström, J F Marshall.   

Abstract

Integrins are a family of heterodimeric cell surface receptors, which are expressed on most cells where they mediate cell-cell and cell-extracellular matrix (ECM) interactions. The alphavbeta6 integrin is epithelial-specific and binds to the ECM proteins fibronectin, vitronectin and tenascin, and also to the latency associated peptide of TGF-beta. Unlike most epithelial integrins, alphavbeta6 is not expressed constitutively by healthy oral epithelia, but is up-regulated during tissue remodelling, including that accompanying wound healing and carcinogenesis. Although, the data at present have been generated principally from in vitro studies, there is increasing evidence to suggest that alphavbeta6 may promote carcinoma progression: alphavbeta6 has been shown to modulate invasion, inhibit apoptosis, regulate protease expression and activate TGF-beta1. This review examines the current literature, and discusses the possible role of alphavbeta6 in wound healing, and in the development and progression of oral squamous cell carcinoma.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16393247     DOI: 10.1111/j.1600-0714.2005.00374.x

Source DB:  PubMed          Journal:  J Oral Pathol Med        ISSN: 0904-2512            Impact factor:   4.253


  59 in total

Review 1.  Integrins as triggers of Epstein-Barr virus fusion and epithelial cell infection.

Authors:  Lindsey M Hutt-Fletcher; Liudmila S Chesnokova
Journal:  Virulence       Date:  2010 Sep-Oct       Impact factor: 5.882

2.  Fusion of Epstein-Barr virus with epithelial cells can be triggered by αvβ5 in addition to αvβ6 and αvβ8, and integrin binding triggers a conformational change in glycoproteins gHgL.

Authors:  Liudmila S Chesnokova; Lindsey M Hutt-Fletcher
Journal:  J Virol       Date:  2011-09-28       Impact factor: 5.103

Review 3.  Integrin-mediated regulation of epidermal wound functions.

Authors:  C Michael DiPersio; Rui Zheng; James Kenney; Livingston Van De Water
Journal:  Cell Tissue Res       Date:  2016-06-28       Impact factor: 5.249

4.  Preclinical Development and First-in-Human Imaging of the Integrin αvβ6 with [18F]αvβ6-Binding Peptide in Metastatic Carcinoma.

Authors:  Sven H Hausner; Richard J Bold; Lina Y Cheuy; Helen K Chew; Megan E Daly; Ryan A Davis; Cameron C Foster; Edward J Kim; Julie L Sutcliffe
Journal:  Clin Cancer Res       Date:  2018-11-06       Impact factor: 12.531

Review 5.  Endocytosis and spatial restriction of cell signaling.

Authors:  Andrea Disanza; Emanuela Frittoli; Andrea Palamidessi; Giorgio Scita
Journal:  Mol Oncol       Date:  2009-06-06       Impact factor: 6.603

6.  Fusion of epithelial cells by Epstein-Barr virus proteins is triggered by binding of viral glycoproteins gHgL to integrins alphavbeta6 or alphavbeta8.

Authors:  Liudmila S Chesnokova; Stephen L Nishimura; Lindsey M Hutt-Fletcher
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-17       Impact factor: 11.205

Review 7.  Epithelial integrins with special reference to oral epithelia.

Authors:  H Larjava; L Koivisto; L Häkkinen; J Heino
Journal:  J Dent Res       Date:  2011-03-25       Impact factor: 6.116

Review 8.  Defining the role of integrin alphavbeta6 in cancer.

Authors:  A Bandyopadhyay; S Raghavan
Journal:  Curr Drug Targets       Date:  2009-07       Impact factor: 3.465

9.  Stromal cell-derived factor-1 (SDF-1) enhances cells invasion by αvβ6 integrin-mediated signaling in ovarian cancer.

Authors:  Baoyao Xue; Weiguang Wu; Kan Huang; Tingting Xie; Xiaobo Xu; Hongju Zhang; Chunlei Qi; Junli Ge; Yuecheng Yu
Journal:  Mol Cell Biochem       Date:  2013-04-25       Impact factor: 3.396

10.  The role of integrins in cancer and the development of anti-integrin therapeutic agents for cancer therapy.

Authors:  Xinjie Lu; Dong Lu; Mike Scully; Vijay Kakkar
Journal:  Perspect Medicin Chem       Date:  2008-04-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.